AI & ChatGPT searches , social queries for TYROSINEMIA
Search references for TYROSINEMIA. Phrases containing TYROSINEMIA
See searches and references containing TYROSINEMIA!
Search references for TYROSINEMIA. Phrases containing TYROSINEMIA
See searches and references containing TYROSINEMIA!TYROSINEMIA
Medical condition
of untreated tyrosinemia include liver and kidney disturbances. Without treatment, tyrosinemia leads to liver failure. Today, tyrosinemia is increasingly
Tyrosinemia
Medical condition
Tyrosinemia type I is a genetic disorder that disrupts the metabolism of the amino acid tyrosine, resulting in damage primarily to the liver along with
Tyrosinemia_type_I
Medication
Orfadin among others, is a medication used for the treatment of hereditary tyrosinemia type 1; or for the reduction of urine homogentisic acid in adults with
Nitisinone
Medical condition
Tyrosinemia type II is an autosomal recessive condition with onset between ages 2 and 4 years, when painful circumscribed calluses develop on the pressure
Tyrosinemia_type_II
GeneReviews/NIH/NCBI/UW entry on Tyrosinemia Type 1, FAH Deficiency, Hepatorenal Tyrosinemia, Hereditary Tyrosinemia Type I, Fumarylacetoacetase Deficiency
Fumarylacetoacetate_hydrolase
Medical condition
Tyrosinemia type III is a rare disorder caused by a deficiency of the enzyme 4-hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27), encoded by the gene
Tyrosinemia_type_III
Class of genetic diseases
disease G6PD deficiency Disorders of amino acid metabolism phenylketonuria tyrosinemia maple syrup urine disease glutaric acidemia type 1 Urea Cycle Disorder
Inborn_errors_of_metabolism
American biochemist
biochemist, who discovered tyrosinosis—a metabolic disorder today known as tyrosinemia—and studied fatty acid metabolism. She was awarded the Garvan-Olin Medal
Grace_Medes
Chemical compound
are indicative of tyrosinemia type 1. Measurement of succinylacetone is the preferred marker in newborn screening of Tyrosinemia Type 1 due to its high
Succinylacetone
Mammalian protein found in Homo sapiens
deficiency of the enzyme in humans can result in what is known as type II tyrosinemia, wherein there is an abundance of tyrosine as a result of tyrosine failing
Tyrosine_aminotransferase
Amino acid
Iodinated tyrosine derivatives Pauly reaction Tyramine Tyrosine sulfation Tyrosinemia Frey MN, Koetzle TF, Lehmann MS, Hamilton WC (1973). "Precision neutron
Tyrosine
Fe(II)-containing non-heme oxygenase
homogentisate in the blood stream. HPPD is also directly linked to Type III tyrosinemia When the active HPPD enzyme concentration is low in the human body, it
4-Hydroxyphenylpyruvate dioxygenase
4-Hydroxyphenylpyruvate_dioxygenase
Property of being from the same kinship as another person
has led to the province having a higher rate of hypercholesterolemia, tyrosinemia, spastic ataxia, intestinal atresia, myotonic dystrophy, etc., in the
Consanguinity
Medical condition
4-hydroxyphenylpyruvate dioxygenase. Complete deficiency of this enzyme would lead to tyrosinemia III. In rare cases, however, the enzyme is still able to produce the
Hawkinsinuria
Abnormal intolerance to visual perception of light
Magnesium deficiency Mercury poisoning Migraine Mustard gas exposure Rabies Tyrosinemia type II Superior canal dehiscence syndrome[not specific enough to verify]
Photophobia
Medical condition
Both lead poisoning and succinylacetone, whose levels are increased in tyrosinemia type I, inhibit ALAD. Therefore, these conditions should also be considered
Aminolevulinic acid dehydratase deficiency porphyria
Aminolevulinic_acid_dehydratase_deficiency_porphyria
Medical condition
Papillon–Lefèvre syndrome Palmoplantar ectodermal dysplasia type 5 or Tyrosinemia type II Palmoplantar ectodermal dysplasia type 6 or Olmsted syndrome
Palmoplantar ectodermal dysplasia
Palmoplantar_ectodermal_dysplasia
Diet in which people decrease their intake of protein
phenylketonuria may differ substantially from that used for homocystinuria, tyrosinemia, chronic kidney disease, or liver disease. By studying the composition
Low-protein_diet
Medical term meaning "characteristic for a particular disease"
disease in a child with Henoch–Schönlein purpura, or succinylacetone for Tyrosinemia Type I.[citation needed] As opposed to symptoms (reported subjectively
Pathognomonic
Medical condition
Endocrinology Differential diagnosis Phenylketonuria (PKU), BH4 Deficiency (Tetrahydrobiopterin Deficiency), Tyrosinemia. Frequency 15–75 per 1,000,000 births.
Hyperphenylalaninemia
Metabolic disorders in which porphyrins build up in the body
dehydratase deficiency or in patients with symptoms due to hereditary tyrosinemia type I. In cases of mercury- or arsenic poisoning-induced porphyria,
Porphyria
Medicine focused on hereditary disorders
enzymes affected by deficiency of biotinidase, treatment with NTBC in Tyrosinemia to inhibit the production of succinylacetone which causes liver toxicity
Medical_genetics
Kidney disorder
genetically inherited condition of copper metabolism), Lowe syndrome, tyrosinemia (type I), galactosemia, glycogen storage diseases, and hereditary fructose
Fanconi_syndrome
Medical condition
syndrome Corneodermatosseous syndrome Huriez syndrome Oculocutaneous tyrosinemia Cardiofaciocutaneous syndrome Schöpf–Schulz–Passarge syndrome Acquired
Keratoderma
Class of herbicides
member of this class and is used to treat an orphan disease, type I tyrosinemia. HPPD inhibitors can be classified into three fundamental chemical frameworks:
4-Hydroxyphenylpyruvate dioxygenase inhibitor
4-Hydroxyphenylpyruvate_dioxygenase_inhibitor
keratoderma, punctate porokeratosis of the palms and soles) Tyrosinemia type II (oculocutaneous tyrosinemia, Richner–Hanhart syndrome) Vohwinkel syndrome (keratoderma
List_of_skin_conditions
Human chromosome
syndrome, (COL2A1-related) Stuttering Triose Phosphate Isomerase deficiency tyrosinemia Von Willebrand Disease G-banding ideograms of human chromosome 12 "Search
Chromosome_12
Medical condition
glycogen storage diseases, porphyria cutanea tarda, Wilson's disease, tyrosinemia have all been associated with development of HCC. Oral contraceptive
Liver_cancer
Medical condition
deficiency Methylmalonic acidemia Maple syrup urine disease Homocystinuria Tyrosinemia Trimethylaminuria Hartnup disease Biotinidase deficiency Ornithine carbamoyltransferase
Congenital disorders of amino acid metabolism
Congenital_disorders_of_amino_acid_metabolism
Medical condition
melasma, and prescribe a hydroquinone-containing cream. Alkaptonuria Tyrosinemia Phenylketonuria List of cutaneous conditions Findlay GH, Morrison JG
Ochronosis
Class of enzymes
to more severe diseases such as, phenylketonuria, alkaptonuria, and tyrosinemia. The gene GSTZ1 is located on chromosome 14q24.3. PDB: 1FW1; Polekhina
Maleylacetoacetate_isomerase
Practice of testing infants for diseases
of amino acid metabolism tested for on the newborn screening include Tyrosinemia and Maple Syrup Urine Disorder.[citation needed] With the advent of tandem
Newborn_screening
Common type of liver cancer
porphyria cutanea tarda, hereditary coproporphyria, variegate porphyria) and tyrosinemia type I are risk factors for hepatocellular carcinoma. The diagnosis of
Hepatocellular_carcinoma
Hepatoblastoma Hepatocellular carcinoma Hepatorenal syndrome Hepatorenal tyrosinemia Herpes Hereditary a – Hereditary m Hereditary amyloidosis Hereditary
List_of_diseases_(H)
negative Oculocutaneous albinism, tyrosinase positive Oculocutaneous tyrosinemia Oculodental syndrome Rutherfurd syndrome Oculodentodigital dysplasia
List_of_diseases_(O)
S/Beta-Thalassemia (Hb S/Th) > 1 in 50,000 Inborn errors of amino acid metabolism Tyrosinemia I (TYR I) < 1 in 100,000 Argininosuccinic aciduria (ASA) < 1 in 100,000
List of disorders included in newborn screening programs
List_of_disorders_included_in_newborn_screening_programs
Human chromosome
syndrome Nonsyndromic deafness Schaaf–Yang syndrome (SYS) Tay–Sachs disease Tyrosinemia Autosomal Dominant Compelling Helio-Ophthalmic Outburst syndrome G-banding
Chromosome_15
Histidine metabolism disease that involves a deficiency of the enzyme histidase
neonatal screening of over 20 million newborns. Prolinemia Sarcosinemia Tyrosinemia Taylor RG, Levi HL, McInnes RR (1991). "Histidase and histidinemia. Clinical
Histidinemia
565.066.766.500 – phenylketonuria, maternal MeSH C16.320.565.066.880 – tyrosinemias MeSH C16.320.565.088 – amino acid transport disorders, inborn MeSH C16
List_of_MeSH_codes_(C16)
Relationship between cancer and the consumption of alcohol
evidence of hepatotropic viruses, hemochromatosis and alcoholic cirrhosis. Tyrosinemia Type I, an inherited disorder in tyrosine metabolism impacting the second
Alcohol_and_cancer
American professor, pediatric physician, and genetic researcher
hydrolase (Fah). This mouse strain has been a useful model of Type I tyrosinemia, a human genetic disease caused by inactivating mutations in the Fah
Markus_Grompe
Medical condition
Hypermethioninemia can occur with other metabolic disorders, such as homocystinuria, tyrosinemia and galactosemia, which also involve the faulty breakdown of particular
Hypermethioninemia
Turner-like syndrome Turner's syndrome Tutuncuoglu syndrome Twin-to-twin transfusion syndrome Typhoid Typhus Tyrosinemia Tyrosine-oxidase temporary deficiency
List_of_diseases_(T)
Drug delivery method
in which the altered gene product is produced in the liver, such as tyrosinemia, and transthyretin amyloidosis, respectively, and the addition of a SORT
Selective_organ_targeting
Medical condition
type I Pachyonychia congenita type II Striate palmoplantar keratoderma Tyrosinemia type II punctate: Acrokeratoelastoidosis of Costa Focal acral hyperkeratosis
Gerodermia_osteodysplastica
Chemical compound
acetoacetic acid Fumarylacetoacetate may accumulate in patients with Tyrosinemia type I, in which there is a deficiency of the FAH enzyme. In this disease
Fumarylacetoacetic_acid
Medical condition
storage disease (type I) Hereditary fructose intolerance Lowe syndrome Tyrosinemia Wilson's disease Acquired disorders Amyloidosis Multiple myeloma Paroxysmal
Proximal renal tubular acidosis
Proximal_renal_tubular_acidosis
dehydrogenase complex deficiency disease MeSH C10.228.140.163.100.875 – tyrosinemias MeSH C10.228.140.163.360 – hepatic encephalopathy MeSH C10.228.140.163
List_of_MeSH_codes_(C10)
211900; GALNT3 Tyrosine kinase 2 deficiency; 611521; TYK2 Tyrosinemia type II; 277660; TAT Tyrosinemia type III; 276710; HPD Ullrich congenital muscular dystrophy;
List_of_OMIM_disorder_codes
Rare benign tumor of the liver
Incidence of adenomas may be increased in metabolic diseases, including tyrosinemia and type 1 diabetes mellitus, and glycogen storage diseases (types 1
Hepatocellular_adenoma
Protein-coding gene in the species Homo sapiens
diseases such as alkaptonuria, phenylketonuria, and several forms of tyrosinemia. A lack of GSTZ1, specifically, leads to the amalgamation of maleylacetoacetate
GSTZ1
discovers tyrosinosis, the metabolic disorder later known as Type I tyrosinemia. Swedish neurosurgeon Herbert Olivecrona performs the first surgical
1932_in_science
dehydrogenase complex deficiency disease MeSH C18.452.100.100.875 – tyrosinemias MeSH C18.452.100.360 – hepatic encephalopathy MeSH C18.452.100.480 –
List_of_MeSH_codes_(C18)
TYROSINEMIA
TYROSINEMIA
TYROSINEMIA
TYROSINEMIA
TYROSINEMIA
TYROSINEMIA
TYROSINEMIA
TYROSINEMIA
TYROSINEMIA